Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats.
BACKGROUND
Pain contains both sensory and affective dimensions. Using a rodent visceral pain assay that combines the colorectal distension (CRD) model with the conditioned place avoidance (CPA) paradigms, we measured a learned behavior that directly reflects the affective component of visceral pain, and showed that perigenual anterior cingulate cortex (pACC) activation is critical for memory processing involved in long-term visceral affective state and prediction of aversive stimuli by contextual cue. Progress has been made and suggested that activation of vagal afferents plays a role in the behavioral control nociception and memory storage processes.In human patients, electrical vagus nerve stimulation enhanced retention of verbal learning performance. Cholecystokinin-octapeptide (CCK), which is a gastrointestinal hormone released during feeding, has been shown to enhance memory retention. Mice access to food immediately after training session enhanced memory retention. It has been well demonstrated that CCK acting on vagal afferent fibers mediates various physiological functions. We hypothesize that CCK activation of vagal afferent enhances visceral pain-related affective memory.


RESULTS
In the presented study, infusion of CCK-8 at physiological concentration combining with conditional training significantly increased the CRD-induced CPA scores, and enhanced the pain affective memory retention. In contrast, CCK had no effect on CPA induced by non-nociceptive aversive stimulus (U69,593). The physiological implications were further strengthened by the similar effects observed in the rats with duodenal infusion of 5% peptone, which has been shown to induce increases in plasma CCK levels. CCK-8 receptor antagonist CR-1409 or perivagal application of capsaicin abolished the effect of CCK on aversive visceral pain memory, which was consistent with the notion that vagal afferent modulates affective aspects of visceral pain. CCK does not change the nociceptive response (visceral pain sensitivity) and anterior cingulate cortex neuronal responses to CRD.


CONCLUSIONS
CCK activating vagal afferent C fibers enhances memory consolidation and retention involved in long-term visceral negative affective state. Thus, in a number of gastrointestinal disorders, such as irritable bowel syndrome, nutrient content may contribute to painful visceral perception by enhancing visceral aversive memory via acts on vagal afferent pathway.
Neuroscience Laboratory, Department of Biology and Chemistry, City University of Hong Kong, Kowloon, Hong Kong, China.
Bing
B
Cao
Xu
X
Zhang
Ni
N
Yan
Shengliang
S
Chen
Ying
Y
Li
D000344:Afferent Pathways / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D044482:Benzeneacetamides / Q000494:pharmacology; D001710:Biotin / Q000031:analogs & derivatives / Q000494:pharmacology; D002211:Capsaicin / Q000008:administration & dosage / Q000494:pharmacology; D003106:Colon / Q000187:drug effects / Q000473:pathology; D003213:Conditioning, Psychological / Q000187:drug effects; D006179:Gyrus Cinguli / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010461:Peptones / Q000008:administration & dosage / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors / Q000378:metabolism; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000378:metabolism; D012007:Rectum / Q000187:drug effects / Q000473:pathology; D012844:Sincalide / Q000008:administration & dosage / Q000494:pharmacology*; D014630:Vagus Nerve / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology*; D059265:Visceral Pain / Q000473:pathology* / Q000503:physiopathology
D044482:Benzeneacetamides; D010461:Peptones; D011759:Pyrrolidines; D011949:Receptors, Cholecystokinin; D017473:Receptors, Opioid, kappa; C070614:neurobiotin; D001710:Biotin; C045444:U 69593; D012844:Sincalide; D002211:Capsaicin